Nasdaq

Masimo's (MASI) SedLine Receives FDA's Pediatric Indication

Masimo Corporation MASI recently received the FDA’s clearance for SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG (electroencephalogram) ...
Nasdaq

Masimo : FDA Oks Pediatric Indication For SedLine Brain Function Monitoring And EEG Sensor

(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
Business Wire

Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine ® Brain Function Monitoring

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® brain function monitoring for pediatric patients (1-18 years of age). With ...
Houston Chronicle

Study Favors Masimo's (MASI) SedLine for Better Patient Outcome

Masimo Corporation MASI recently announced the findings of a favorable study result wherein researchers evaluated the relationship between parameters derived from electroencephalogram (EEG) spectra ...